CapsoVision (NASDAQ:CV) executives used a fireside chat hosted by Roth Senior Research Analyst Kyle Bauser to outline the company’s origins, its capsule endoscopy platform for small bowel ...

(the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the closing of a $14 million private ...

Ingestible smart capsules deliver medication directly to specific gut locations using microscopic needles and targeted drug release systems.

A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection of Oesophageal and stomach cancers, some of the hardest cancers to diagnose ...

NHS Suffolk and North East Essex ICB launches UK-first AI cancer detection programme with AstraZeneca and C the Signs to boost early diagnosis ...

People on Wirral are being invited to join a 'ground-breaking' clinical trial ...

Monitoring symptoms, recognizing unusual changes taking place in the body and following screening guidelines are among the best steps people can take to help prevent colorectal cancer, […] ...

People on the Isle of Wight are taking part in a ground-breaking clinical trial which could pave the way for a new national screening programme for oesophageal cancer.

Endoscopic ultrasound-guided gastrojejunostomy offers the best clinical success among all other techniques used for palliation of malignant gastric outlet obstruction.

Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but clear liquids the day before could mitigate the risk.

Residual gastric volume precluded endoscopic examination ...